- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02276404
Preoperative Relaxation Training and Acupuncture to Minimize Perioperative Symptoms in Breast Cancer Patients
13. juni 2019 oppdatert av: Silke Lange, Universität Duisburg-Essen
Entspannung Und Akupunktur Zur Reduktion Perioperativer Symptome Bei Brustkrebspatientinnen- Eine Randomisiert-kontrollierte Interventionsstudie im Kontext Einer Integrativ Onkologischen Versorgung (EARpeS)
Breast cancer surgery is associated with presurgical psychological distress and clinically significant side effects including postsurgical pain, nausea and fatigue.
A few studies have examined how to intervene to assist women undergoing breast cancer surgery.
For example presurgical hypnosis has been proven to decrease side effects and even intraoperative anesthesia use.
Besides the more psychologically based interventions there are a few studies suggesting positive effects of acupuncture on pain, anxiety and nausea in surgery patients.This study aims to investigate whether a presurgical relaxation training, acupuncture treatment or a combination of both therapies is able to reduce presurgical psychological distress an postsurgical side effects in breast cancer patients in comparison to usual care.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
120
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Essen, Tyskland, 45136
- Department of Senology, Kliniken Essen-Mitte
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år til 75 år (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Hunn
Beskrivelse
Inclusion criteria:
- clinically proven breast cancer with an indication for breast conserving surgery with max. 50% volume reduction
- physical and psychological ability to take part in relaxation training
Exclusion criteria:
- serious psychiatric disorder
- to time span to surgery shorter than 2 weeks or longer than 20 weeks
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: relaxation training
Each participant of the experimental group 1 receives 2 one-hour sessions of guided relaxation training prior to surgery.
|
The relaxation sessions comprise an introduction in 3 relaxation techniques conducted by a mind-body therapist: "Body Scan", mindfulness meditation and imagination.
Patients also receive a CD with different relaxation exercises and the instruction to exercise daily at home for at least 15 minutes.
|
Eksperimentell: acupuncture
Each participant of the experimental group 2 receives 3 acupuncture treatments with a semi-standardized acupoint scheme: once a week over 2 weeks and the day before surgery.
|
The acupuncture treatment comprises needling of 6 standardized acupoints: Pericardium 6, Stomach 36, Large intestine 4, Spleen/Pancreas 10, Dumai 20, Liver 3, Shenmen.
Additional points can be chosen individual.
|
Eksperimentell: relaxation training and acupuncture
Each patient of the experimental group 3 receives 3 acupuncture treatments with a semi-standardized acupoint scheme and 2 one-hour sessions of guided relaxation training prior to surgery.
|
The relaxation sessions comprise an introduction in 3 relaxation techniques conducted by a mind-body therapist: "Body Scan", mindfulness meditation and imagination.
Patients also receive a CD with different relaxation exercises and the instruction to exercise daily at home for at least 15 minutes.
The acupuncture treatment comprises needling of 6 standardized acupoints: Pericardium 6, Stomach 36, Large intestine 4, Spleen/Pancreas 10, Dumai 20, Liver 3, Shenmen.
Additional points can be chosen individual.
|
Ingen inngripen: usual care
Patients receive usual senological treatment
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
presurgical psychological distress
Tidsramme: expected average of 13 days
|
Measured by 100mm visual analog scale 1 day pre surgery
|
expected average of 13 days
|
postsurgical pain
Tidsramme: expected average of 15 days
|
Measured by 100mm visual analog scale 1 day post surgery
|
expected average of 15 days
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
postsurgical psychological distress
Tidsramme: expected average of 15 days
|
Measured by 100mm visual analog scale 1 day post surgery
|
expected average of 15 days
|
postsurgical psychological distress
Tidsramme: expected average of 21 days
|
Measured by 100mm visual analog scale 1 week post surgery
|
expected average of 21 days
|
postsurgical pain
Tidsramme: expected average of 21 days
|
Measured by 100mm visual analog scale 1 week post surgery
|
expected average of 21 days
|
postsurgical nausea
Tidsramme: expected average of 15 days
|
Measured by 100mm visual analog scale 1 day post surgery
|
expected average of 15 days
|
postsurgical nausea
Tidsramme: expected average of 21 days
|
Measured by 100mm visual analog scale 1 week post surgery
|
expected average of 21 days
|
postsurgical fatigue
Tidsramme: expected average of 15 days
|
Measured by 100mm visual analog scale 1 day post surgery
|
expected average of 15 days
|
postsurgical fatigue
Tidsramme: expected average of 21 days
|
Measured by 100mm visual analog scale 1 week post surgery
|
expected average of 21 days
|
intraoperative analgesia use
Tidsramme: expected average of 14 days
|
intraoperative analgesia use is taken from operative logs
|
expected average of 14 days
|
intraoperative anesthesia use
Tidsramme: expected average of 14 days
|
intraoperative anesthesia use is taken from operative logs
|
expected average of 14 days
|
postoperative analgesia use
Tidsramme: expected average of 15 days
|
postoperative analgesia use is taken from medical records
|
expected average of 15 days
|
immunemodulation
Tidsramme: expected average of 14 days
|
natural killer cell activity is measured at begin of surgery
|
expected average of 14 days
|
immunemodulation
Tidsramme: expected average of 14 days
|
natural killer cell activity is measured at end of surgery
|
expected average of 14 days
|
Number of patients with adverse events
Tidsramme: expected average of 21 days
|
Number of patients with adverse events are measured one week post surgery
|
expected average of 21 days
|
presurgical psychological distress
Tidsramme: expected average of 13 days
|
Measured by Profile of Mood States (POMS) 1 day pre surgery
|
expected average of 13 days
|
postsurgical psychological distress
Tidsramme: expected average of 15 days
|
Measured by Profile of Mood States (POMS) 1 day post surgery
|
expected average of 15 days
|
postsurgical psychological distress
Tidsramme: expected average of 21 days
|
Measured by Profile of Mood States (POMS) 1 week post surgery
|
expected average of 21 days
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Studiestol: Gustav J. Dobos, Prof, Chair of Complementary and Integrative Medicine, Universitay of Duisburg-Essen, Germany
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. november 2014
Primær fullføring (Faktiske)
1. november 2018
Studiet fullført (Faktiske)
1. november 2018
Datoer for studieregistrering
Først innsendt
21. oktober 2014
Først innsendt som oppfylte QC-kriteriene
27. oktober 2014
Først lagt ut (Anslag)
28. oktober 2014
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
14. juni 2019
Siste oppdatering sendt inn som oppfylte QC-kriteriene
13. juni 2019
Sist bekreftet
1. juni 2019
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 14-5778-BO
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Brystneoplasmer
-
Guangzhou First People's HospitalFullført
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbeidspartnereFullførtThe Clinical Application Guide of Conebeam Breast CTKina
-
Novartis PharmaceuticalsFullførtMetastatisk brystkreft (MBC) | Locally Advance Breast Cancer (LABC)Storbritannia, Spania
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UkjentHR-positiv, HER2-negativ og PIK3CA Mutation Advanced Breast CancerKina
-
Rabin Medical CenterFullførtDesmoid fibromatose | Desmoid | Desmoid fibromatose i huden | Desmoid Neoplasm of Chest Wall | Desmoid-svulst forårsaket av somatisk mutasjon | Aggressive fibromatoser | Fibromatose DesmoidIsrael
-
Emory UniversityNational Cancer Institute (NCI)TilbaketrukketPrognostisk stadium IV brystkreft AJCC v8 | Metastatisk malign neoplasma i hjernen | Metastatisk brystkarsinom | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
NRG OncologyNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeAnatomisk stadium IV brystkreft AJCC v8 | Prognostisk stadium IV brystkreft AJCC v8 | Metastatisk malign neoplasma i beinet | Metastatisk malign neoplasma i lymfeknutene | Metastatisk malign neoplasma i leveren | Metastatisk brystkarsinom | Metastatisk malign neoplasma i lungen | Metastatisk malign neoplasma... og andre forholdForente stater, Canada, Saudi-Arabia, Korea, Republikken
Kliniske studier på relaxation training
-
Trinitas Comprehensive Cancer CenterAptium Oncology Research NetworkUkjent
-
Eduardo Fonseca PedreroPsicofundación: Fundación Española para Promoción, Desarrollo Científico... og andre samarbeidspartnereRekrutteringDepressiv lidelse | Emosjonell lidelse | Angstlidelse | Følelsesmessig problemSpania
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute; Bay Cove Human Services; Vi...Påmelding etter invitasjonEffektiviteten av intervensjoner for å forbedre motstandskraft og utbrenthet i atferdshelsepersonellDepresjon | Understreke | Brenne ut | Sove | Angst | Mestringsferdigheter | Mangel på fysisk aktivitet | Spise suntForente stater
-
Chiang Mai UniversityFullførtHetetokter | Søvnforstyrrelser | NattesvetteThailand
-
University of California, San FranciscoFullført
-
Gadjah Mada UniversityTaipei Medical UniversityFullførtSmerte | Angst | Blodtrykk | Følelse av mestringsevne | Komfort | PulsIndonesia
-
Dana-Farber Cancer InstituteFullførtMonoklonal gammopati av ubestemt betydning | Ulmende myelomatoseForente stater
-
University of JordanFullført
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH)FullførtResiliens, psykologiskForente stater
-
Massachusetts General HospitalThe Children's Tumor FoundationFullførtNevrofibromatose | Nevrofibromatose 2 | Schwannomatose | Nevrofibromatose IForente stater